Home-Based Exercise and Brain Training Tackles Cognitive Decline in Older Adults

Alzheimer's disease and related dementias represent one of the most urgent public health challenges of aging societies. A critical window for intervention exists in individuals with mild cognitive impairment or subjective cognitive concerns — stages where prevention may still be achievable. While both physical exercise and cognitive training have demonstrated benefits in research facility settings, the practical question of whether these interventions can be delivered effectively in people's own homes had not been rigorously tested.

The SYNERGIC@Home trial, sponsored by the University of New Brunswick, addressed this gap directly. Sixty older adults at risk for dementia were enrolled in a 16-week randomized controlled trial using a 2x2 factorial design. Participants were assigned to one of four combinations: aerobic and resistance exercise paired with structured cognitive training (NEUROPEAK™), exercise with control cognitive tasks (web searching and video watching), control exercise (balance and toning) with cognitive training, or both control conditions. All interventions were delivered virtually through video conferencing, making geographic barriers largely irrelevant.

A distinctive feature of this trial was its focus on participant preferences. The researchers explicitly examined whether individuals who received their preferred intervention showed better adherence — a question with major implications for real-world program design and personalized medicine approaches to dementia prevention.

Secondary outcomes captured a broad picture of health, including cognition, frailty, mobility, sleep quality, diet, and psychological wellbeing, with assessments at baseline, 4 months, and 10 months post-intervention. The trial was completed in July 2023, meaning results data should be forthcoming.

If feasibility is confirmed and preference-matched adherence proves superior, this model could redefine scalable dementia prevention — particularly for older adults with mobility limitations or those living in rural or underserved areas. Caveats include the small sample size and the fact that outcome data have not yet been published.